Clinical Trial Update: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome [NA]

View source ↗

Summary

Dose-adjusting enoxaparin thromboprophylaxis based on anti-factor Xa levels during pregnancy may improve outcomes in women at risk for fetal demise, fetal growt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Demise
• Fetal Growth Restriction
• Placental Abruption
• Preeclampsia
• Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Fetal Demise, Fetal Growth Restriction | NA | Status: COMPLETED